References
- 1. Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007 Oct 1;21(15):2101-3.10.1097/QAD.0b013e3282ef1bb417885301
- 2. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004 Sep;66(3):1145-52.10.1111/j.1523-1755.2004.00865.x15327410
- 3. Swanepoel CR, Atta MG, D’Agati VD, Estrella MM, Fogo AB, Naicker S, et al. Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018 Mar;93(3):545-59.
- 4. Streinu-Cercel A, Sandulescu O, Poiana C, Dorobantu M, Mircescu G, Lazureanu VE, et al. Consensus statement on the assessment of comorbidities in people living with HIV in Romania. Germs. 2019 Dec;9(4):198-210.10.18683/germs.2019.1178694265532042727
- 5. Crum-Cianflone N, Ganesan A, Teneza-Mora N, Riddle M, Medina S, Barahona I, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDS. 2010;24(6):353-6010.1089/apc.2009.0326293356120515419
- 6. Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009 Jul;10(6):329-36.10.1111/j.1468-1293.2008.00691.x19226409
- 7. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008 Jun 1;197(11):1548-57.10.1086/587994255320918422458
- 8. Morlat P, Vivot A, Vandenhende MA, Dauchy FA, Asselineau J, Deti E, et al. Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012. PLoS One. 2013;8(6):e66223.10.1371/journal.pone.0066223368043923776637
- 9. Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS. 2012 Sep 24;26(15):1907-15.10.1097/QAD.0b013e328357f5ed353162822824630
- 10. Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010 Jul 17;24(11):1667-7810.1097/QAD.0b013e328339fe5320523203
- 11. Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, et al. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015 Mar;12(3):e1001809.10.1371/journal.pmed.1001809438041525826420
- 12. Yombi JC, Pozniak A, Boffito M, Jones R, Khoo S, Levy J, et al. Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity. AIDS. 2014 Mar 13;28(5):621-32.10.1097/QAD.000000000000010324983540
- 13. Milburn J, Jones R, Levy JB. Renal effects of novel antiretroviral drugs. Nephrol Dial Transplant. 2017 Mar 1;32(3):434-9.
- 14. EACS European AIDS Clinical Society. Guidelines. Version 10.0 November 2019. 2019.
- 15. Kirkpatrick JJ, Leslie SW. Horseshoe Kidney. StatPearls: StatPearls Publishing; 2018.
- 16. Taghavi K, Kirkpatrick J, Mirjalili SA. The horseshoe kidney: Surgical anatomy and embryology. J Pediatr Urol. 2016 Oct;12(5):275-80.10.1016/j.jpurol.2016.04.03327324557
- 17. Natsis K, Piagkou M, Skotsimara A, Protogerou V, Tsitouridis I, Skandalakis P. Horseshoe kidney: a review of anatomy and pathology. Surg Radiol Anat. 2014 Aug;36(6):517-26.10.1007/s00276-013-1229-724178305
- 18. Glodny B, Petersen J, Hofmann KJ, Schenk C, Herwig R, Trieb T, et al. Kidney fusion anomalies revisited: clinical and radiological analysis of 209 cases of crossed fused ectopia and horseshoe kidney. BJU Int. 2009 Jan;103(2):224-35.10.1111/j.1464-410X.2008.07912.x18710445
- 19. Neville H, Ritchey ML, Shamberger RC, Haase G, Perlman S, Yoshioka T. The occurrence of Wilms tumor in horseshoe kidneys: a report from the National Wilms Tumor Study Group (NWTSG). J Pediatr Surg. 2002 Aug;37(8):1134-7.10.1053/jpsu.2002.3445812149688
- 20. Huang EY, Mascarenhas L, Mahour GH. Wilms’ tumor and horseshoe kidneys: a case report and review of the literature. J Pediatr Surg. 2004 Feb;39(2):207-12.10.1016/j.jpedsurg.2003.10.01914966742
- 21. Pawar AS, Thongprayoon C, Cheungpasitporn W, Sakhuja A, Mao MA, Erickson SB. Incidence and characteristics of kidney stones in patients with horseshoe kidney: A systematic review and meta-analysis. Urol Ann. 2018 Jan-Mar;10(1):87-93.10.4103/UA.UA_76_17579146529416282
- 22. Suwannakhan A, Meemon K. Horseshoe kidney with extrarenal calyces and malformed renal vessels. Eur J Anat. 2016;20:355-9.
- 23. Al Otay A, Sarhan O, El-Tholoth HS, Alhelaly A, Al Akrash H, Al Ghanbar M, et al. Different managements of horseshoe kidney stones, any difference in the outcome? Urology annals. 2018 Jul-Sep;10(3):287-90.10.4103/UA.UA_116_17606060130089987
- 24. Hamada Y, Nishijima T, Watanabe K, Komatsu H, Tsukada K, Teruya K, et al. High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy. Clin Infect Dis. 2012 Nov;55(9):1262-9.10.1093/cid/cis62122820542
- 25. Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, et al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis. 2013 May 1;207(9):1359-69.10.1093/infdis/jit043361042423382571
- 26. Perazella MA. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy. Kidney Int. 2010 Dec;78(11):1060-3.10.1038/ki.2010.34421076445
- 27. Waheed S, Attia D, Estrella MM, Zafar Y, Atta MG, Lucas GM, et al. Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series. Clin Kidney J. 2015 Aug;8(4):420-5.10.1093/ckj/sfv041451589626251709
- 28. Gupta SK, Post FA, Arribas JR, Eron JJ, Jr., Wohl DA, Clarke AE, et al. Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials. Aids. 2019 Jul 15;33(9):1455-65.10.1097/QAD.0000000000002223663504330932951